Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Research Associate, Analytical Development (CONTRACT)

Employer
Sutro Biopharma, Inc
Location
South San Francisco, CA
Salary
$95,000 – $120,000
Start date
Jun 14, 2024

Job Details

Sutro Biopharma, Inc. is seeking a Senior Research Associate to join our activity/impurity assay development team which supports Sutro’s clinical candidate pipeline of antibodies, antibody drug conjugates, and additional novel protein/conjugate therapeutics with primary focus on early-stage programs. Responsibilities: 
  • Operate within our analytical group to perform plate-based ELISA, enzymatic, and cell-based activity assays to support upstream/downstream development and formulation development.
  • Work with minimal supervision while also working collaboratively within the Analytical group and across functional groups.
  • Contribute to product characterization studies as well as perform routine release assays.
  • Communicate their data both verbally at group meetings and through written documents and reports. 
  • Contributes to method development and has a technical understanding of the analytical methods and assays.
  • Communicate their data both verbally at group meetings and through written documents and reports.
  • Has an understanding of the cell-free technology and brings that knowledge to the AD group.
  • Work diligently and patiently to run plate-based assays with attention to detail.
  • Has understanding and knowledge of impurity assays such as host cell proteins, Host cell DNA and other impurities from the purification process.
  • Can help support assay optimization and assay qualifications/assessments.
 Qualifications: 
  • PhD, 1+ years or BS, 4+ years industry experience in analytical chemistry, biochemistry, or related scientific field, in the analysis and characterization of monoclonal antibodies/antibody drug conjugates by plate-based assays.
  • Previous experience with commercial impurity kits is preferred.
  • Proficiency in operation of Molecular Devices Softmax Pro is highly preferred.
  • Experience in chromatography assays (SEC, RP-HPLC) and PCR is desirable.
  • Flexibility to work on multiple projects between departments in a fast-paced environment is essential.
  • Excellent verbal communication, strong writing skills, and being detailed oriented are important attributes.
 Sound exciting? Apply today and join our team! Sutro Biopharma, Inc. encourages all colleagues to be fully vaccinated for COVID-19 prior to the first date of employment. 
As an equal opportunity employer, we believe in fostering a culture that is inclusive and values diversity in background and opinions. Sutro Biopharma hires extraordinary individuals into every position in the company and is committed to the diversity of our team. Our company progresses without regard of race, ethnicity, gender, sexual orientation, religious belief, age, disability or citizenship status. We are dedicated to creating a safe environment where our employees can grow and succeed together.     We look forward to hearing from candidates who are interested in exploring opportunities with Sutro! Our People & Culture team/hiring managers are unable to respond and do not accept solicitations from third-party agencies.     The anticipated salary range for fully qualified candidates applying for this role at Sutro Biopharma’s California-based locations will be $95,000 – $120,000. The final salary offered will be dependent on several factors that include and are not limited to relevant previous experience, job responsibilities and duration of experience, the type and length of experience within the industry and education.   About Sutro Biopharma     Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.  

Company

sutro

 

Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.

Stock Symbol: STRO

Twitter

 

yh

Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here 

erf

 

Company info
Website
Phone
650.881.6500
Location
111 Oyster Point Blvd
South San Francisco
California
94080
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert